Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.6 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.48.
Market Cap
9.6T
Revenue
4.66T
Profits
186.48B
PE Ratio
51.48
Profit Margin
4.00%
Dividend Yield
0.37%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.11T | -0.67% | 1,663,868 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 658.00B | 1.04% | 4,686,703 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 467.44B | -0.17% | 2,185,753 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 371.70B | -1.24% | 14,663,646 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 357.92B | 2.22% | 4,683,408 | 450.53B |
| 6 | NVS | Novartis AG | 300.52B | -0.53% | 801,030 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 256.25B | 0.44% | 2,780,063 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.95B | 1.03% | 2,372,212 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.47B | -0.08% | 1,719,277 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.64B | 0.39% | 9,652,046 | 50.34B |
| 11 | ABT | Abbott Laboratories | 201.88B | 0.03% | 5,854,409 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.95B | 0.42% | 6,182,750 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.42B | -0.36% | 23,810,174 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.22B | -1.71% | 2,510,198 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.79B | -0.08% | 766,875 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.43B | 0.40% | 5,421,271 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.97B | -1.38% | 1,517,026 | 11.03B |
| 18 | SYK | Stryker Corporation | 125.74B | -0.50% | 1,878,049 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.36B | 1.17% | 6,383,708 | 412.65B |
| 20 | MDT | Medtronic plc | 118.91B | -0.48% | 5,975,672 | 36.36B |
| 21 | SNY | Sanofi | 109.43B | -0.35% | 1,719,097 | 55.89B |
| 22 | GSK | GSK plc | 104.78B | -1.20% | 2,886,022 | 44.05B |
| 23 | MCK | McKesson Corporation | 101.88B | 1.73% | 600,380 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 92.93B | 0.01% | 1,306,654 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.32B | 0.52% | 805,531 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.73B | -0.66% | 671,942 | 15.53B |
| 27 | CI | The Cigna Group | 74.11B | 1.06% | 1,736,047 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.03B | -2.70% | 22,023,432 | 21.00B |
| 29 | ARGX | argenx SE | 63.06B | -2.76% | 318,415 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.78B | 1.80% | 753,732 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.19B | 0.33% | 2,130,976 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 55.45B | -4.30% | 31,696,449 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.04B | 1.25% | 1,317,269 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.16B | 0.79% | 2,676,650 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.96B | -0.66% | 1,297,201 | 22.48B |
| 36 | NTRA | Natera, Inc. | 47.24B | -1.30% | 1,219,215 | 2.71B |
| 37 | HUM | Humana Inc. | 46.42B | 2.04% | 1,454,978 | 145.68B |
| 38 | MDLN | Medline Inc. | 45.62B | 1.28% | 5,576,348 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.35B | 1.01% | 1,597,883 | - |
| 40 | HLN | Haleon plc | 44.44B | 1.60% | 13,657,422 | 14.80B |
| 41 | IDXX | IDEXX Laboratories, Inc. | 44.08B | 0.46% | 382,909 | 4.55B |
| 42 | A | Agilent Technologies, Inc. | 43.33B | -3.50% | 3,945,882 | 7.23B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.03B | -1.10% | 3,338,114 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 42.84B | 0.16% | 1,113,624 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.29B | -0.66% | 343,567 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 40.36B | 0.23% | 1,569,552 | 3.32B |
| 47 | WAT | Waters Corporation | 40.36B | 0.01% | 590,971 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.53B | 0.10% | 1,159,810 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.26B | 0.03% | 2,346,651 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.36B | -1.39% | 4,396,437 | 4.97B |
| 51 | ILMN | Illumina, Inc. | 33.71B | 1.74% | 2,249,611 | 4.49B |
| 52 | RMD | ResMed Inc. | 33.53B | 0.40% | 1,113,366 | 5.65B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.51B | -0.84% | 2,426,676 | 21.27B |
| 54 | CNC | Centene Corporation | 32.43B | 0.97% | 3,490,741 | 180.30B |
| 55 | BIIB | Biogen Inc. | 32.23B | 0.62% | 649,817 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.89B | -0.72% | 4,065,749 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.58B | -0.09% | 2,091,244 | 4.80B |
| 58 | BNTX | BioNTech SE | 28.34B | -3.22% | 1,831,554 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.03B | 0.26% | 164,010 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 27.52B | 0.89% | 462,504 | 14.35B |
| 61 | INSM | Insmed Incorporated | 27.07B | -1.42% | 1,340,546 | 1.14B |
| 62 | PHG | Koninklijke Philips N.V. | 26.93B | 0.36% | 566,562 | 20.18B |
| 63 | DGX | Quest Diagnostics Incorporated | 26.92B | -0.21% | 802,589 | 11.56B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.26B | 0.17% | 5,117,075 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.94B | 0.13% | 799,410 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.87B | 0.07% | 472,559 | 3.33B |
| 67 | STE | STERIS plc | 23.19B | -0.03% | 360,934 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 22.43B | -0.78% | 752,421 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 22.00B | -0.05% | 323,873 | 3.15B |
| 70 | GH | Guardant Health, Inc. | 21.90B | -4.40% | 1,968,855 | 1.18B |
| 71 | GMAB | Genmab A/S | 19.69B | -1.29% | 3,246,442 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.26B | - | 1,499,666 | 8.51B |
| 73 | VTRS | Viatris Inc. | 19.00B | 1.35% | 3,778,502 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.31B | -0.12% | 185,026 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.55B | -0.53% | 329,915 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.52B | 0.07% | 419,912 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.85B | -0.53% | 1,113,353 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.56B | 0.31% | 1,207,514 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.53B | 1.88% | 1,144,696 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.78B | -0.55% | 1,140,704 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.25B | 1.15% | 786,058 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.73B | -1.40% | 1,445,964 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.70B | 0.57% | 4,426,503 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.52B | 0.87% | 2,422,929 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.38B | 0.73% | 420,647 | 8.29B |
| 86 | CORT | Corcept Therapeutics Incorporated | 13.32B | 0.81% | 1,012,648 | 830.81M |
| 87 | PEN | Penumbra, Inc. | 12.75B | -0.44% | 144,264 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.60B | -2.44% | 2,264,338 | 3.41B |
| 89 | FMS | Fresenius Medical Care AG | 12.46B | 0.43% | 510,715 | 22.19B |
| 90 | SNN | Smith & Nephew plc | 12.42B | 1.23% | 1,051,733 | 6.30B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.39B | 1.05% | 2,185,655 | 14.37B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.33B | 0.43% | 2,090,526 | 1.66B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.25B | -0.44% | 1,104,360 | 669.50M |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.20B | 1.88% | 3,952,062 | 5.02B |
| 95 | TEM | Tempus AI, Inc. | 11.94B | -8.97% | 11,878,404 | 1.43B |
| 96 | EHC | Encompass Health Corporation | 11.93B | 0.51% | 688,145 | 6.21B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.83B | -0.92% | 145,147 | 1.28B |
| 98 | TECH | Bio-Techne Corporation | 11.35B | 0.10% | 1,359,587 | 1.22B |
| 99 | ALGN | Align Technology, Inc. | 11.34B | -1.79% | 761,962 | 4.14B |
| 100 | GMED | Globus Medical, Inc. | 11.29B | -3.26% | 1,132,276 | 3.14B |
| 101 | DVA | DaVita Inc. | 11.26B | 1.54% | 1,090,437 | 14.01B |
| 102 | GKOS | Glaukos Corporation | 10.95B | 0.41% | 622,276 | 612.84M |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.76B | -1.14% | 292,776 | 776.57M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.72B | 0.33% | 1,210,572 | 67.67M |
| 105 | ABVX | ABIVAX Société Anonyme | 10.71B | 1.04% | 1,138,209 | 5.67M |
| 106 | UHS | Universal Health Services, Inc. | 10.40B | -0.49% | 547,894 | 18.11B |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.39B | 0.33% | 2,069,530 | 3.50B |
| 108 | ENSG | The Ensign Group, Inc. | 10.37B | -0.06% | 258,629 | 5.49B |
| 109 | MOH | Molina Healthcare, Inc. | 10.34B | -0.89% | 555,903 | 42.47B |
| 110 | IONS | Ionis Pharmaceuticals, Inc. | 10.31B | 3.85% | 2,206,470 | 874.09M |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.28B | -2.10% | 265,005 | 7.46M |
| 112 | RGEN | Repligen Corporation | 10.25B | 0.27% | 1,493,278 | 785.10M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 10.21B | 0.46% | 296,960 | 2.59B |
| 114 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.03% | 1,148,993 | - |
| 115 | SMMT | Summit Therapeutics Inc. | 10.16B | -3.27% | 3,678,041 | - |
| 116 | KRYS | Krystal Biotech, Inc. | 10.11B | -1.40% | 236,181 | 440.48M |
| 117 | PODD | Insulet Corporation | 10.09B | -1.85% | 1,568,481 | 3.05B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 10.07B | 1.04% | 465,873 | 105.00M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 10.01B | 0.26% | 476,085 | 281.99M |
| 120 | HSIC | Henry Schein, Inc. | 9.98B | 1.14% | 653,579 | 13.60B |
| 121 | OSCR | Oscar Health, Inc. | 9.81B | -0.72% | 4,681,088 | 15.32B |
| 122 | AVTR | Avantor, Inc. | 9.64B | -1.38% | 5,192,649 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.40B | 0.15% | 640,568 | - |
| 124 | PCVX | Vaxcyte, Inc. | 9.21B | -1.20% | 662,064 | - |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.11% | 908,497 | 42.16M |
| 126 | IMVT | Immunovant, Inc. | 8.95B | -2.37% | 1,149,421 | - |
| 127 | TWST | Twist Bioscience Corporation | 8.83B | -3.29% | 1,804,757 | 431.80M |
| 128 | HQY | HealthEquity, Inc. | 8.81B | -0.01% | 512,578 | 1.34B |
| 129 | BRKR | Bruker Corporation | 8.68B | -4.33% | 1,174,219 | 3.50B |
| 130 | QGEN | Qiagen N.V. | 8.64B | -5.20% | 6,995,085 | 2.10B |
| 131 | ATR | AptarGroup, Inc. | 8.57B | -0.04% | 282,301 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.31B | -2.03% | 3,741,896 | 616.91M |
| 133 | ALKS | Alkermes plc | 8.20B | 1.12% | 1,296,443 | 1.67B |
| 134 | IBRX | ImmunityBio, Inc. | 8.03B | -2.70% | 5,611,807 | 165.79M |
| 135 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.21% | 2,300,065 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.67B | 1.31% | 399,301 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.38B | -0.53% | 5,801,578 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.26B | 1.76% | 2,580,176 | 720.06M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.25B | -7.99% | 12,730,082 | 2.58B |
| 140 | SRRK | Scholar Rock Holding Corporation | 7.09B | 3.01% | 1,207,308 | - |
| 141 | CHE | Chemed Corporation | 7.05B | 0.14% | 124,486 | 2.60B |
| 142 | PACS | PACS Group, Inc. | 7.01B | - | 544,941 | 5.55B |
| 143 | GRFS | Grifols, S.A. | 6.94B | -0.12% | 227,285 | 8.48B |
| 144 | CGON | CG Oncology, Inc. | 6.93B | -1.98% | 1,158,403 | 6.23M |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.78B | -5.13% | 992,194 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.83% | 1,008,971 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.40B | -1.36% | 135,333 | - |
| 148 | LQDA | Liquidia Corporation | 6.29B | 2.40% | 1,291,094 | 450.91M |
| 149 | COGT | Cogent Biosciences, Inc. | 6.29B | -1.36% | 985,120 | - |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | 0.43% | 367,572 | 618.07M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.19B | 0.44% | 418,629 | 840.85M |
| 152 | BLCO | Bausch + Lomb Corporation | 6.19B | 0.46% | 290,493 | 5.32B |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.16B | -0.93% | 529,833 | 1.90M |
| 154 | ERAS | Erasca, Inc. | 6.16B | -0.17% | 2,244,359 | - |
| 155 | TVTX | Travere Therapeutics, Inc. | 6.15B | -0.75% | 1,035,322 | 591.33M |
| 156 | STVN | Stevanato Group S.p.A. | 6.08B | -1.46% | 1,309,683 | 1.40B |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.93B | 1.78% | 897,681 | 1.01B |
| 158 | RDNT | RadNet, Inc. | 5.88B | -2.77% | 545,667 | 2.27B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.86B | -0.35% | 628,813 | 7.50M |
| 160 | TFX | Teleflex Incorporated | 5.86B | -0.37% | 630,603 | 2.25B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.81B | -3.65% | 1,719,974 | - |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 5.68B | -0.73% | 1,369,872 | 3.12B |
| 163 | MMED | MiniMed Group, Inc. | 5.60B | -2.49% | 813,763 | 3.10B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -2.13% | 157,244 | 290.54M |
| 165 | CRSP | CRISPR Therapeutics AG | 5.52B | -4.08% | 1,117,747 | 13.39M |
| 166 | SHC | Sotera Health Company | 5.47B | -2.04% | 1,905,689 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.39B | -0.55% | 636,652 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.11B | 0.51% | 1,489,591 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.93B | -0.37% | 641,042 | 1.35B |
| 170 | WAY | Waystar Holding Corp. | 4.86B | 1.36% | 3,366,644 | 1.21B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.86B | 1.22% | 1,013,091 | - |
| 172 | DYN | Dyne Therapeutics, Inc. | 4.85B | -0.42% | 1,370,091 | - |
| 173 | PBLS | Parabilis Medicines, Inc. | 4.75B | -2.36% | 340,269 | 148.00K |
| 174 | LFST | LifeStance Health Group, Inc. | 4.65B | -2.49% | 2,722,655 | 1.58B |
| 175 | ICUI | ICU Medical, Inc. | 4.57B | -0.16% | 225,697 | 2.16B |
| 176 | BLLN | BillionToOne, Inc. | 4.56B | 1.80% | 548,479 | 397.41M |
| 177 | DOCS | Doximity, Inc. | 4.51B | -0.12% | 2,628,066 | 655.57M |
| 178 | ELVN | Enliven Therapeutics, Inc. | 4.48B | 2.22% | 1,255,203 | - |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | -0.03% | 566,202 | 2.29B |
| 180 | CELC | Celcuity Inc. | 4.44B | -2.93% | 513,979 | - |
| 181 | NVST | Envista Holdings Corporation | 4.39B | 0.51% | 1,793,802 | 2.86B |
| 182 | HTFL | HeartFlow, Inc. | 4.37B | 0.90% | 2,294,564 | 212.07M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.33B | 1.65% | 2,639,366 | 10.35M |
| 184 | LIVN | LivaNova PLC | 4.31B | -0.61% | 424,947 | 1.47B |
| 185 | INDV | Indivior Pharmaceuticals, Inc. | 4.27B | -1.87% | 1,839,697 | 1.33B |
| 186 | ITGR | Integer Holdings Corporation | 4.25B | -0.10% | 752,534 | 1.84B |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.25B | -1.32% | 3,707,928 | -665.00K |
| 188 | TNGX | Tango Therapeutics, Inc. | 4.13B | 2.64% | 2,088,598 | 53.81M |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.13B | -2.54% | 357,693 | 825.34M |
| 190 | MANE | Veradermics, Incorporated | 4.11B | -4.24% | 717,276 | - |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -1.69% | 1,694,323 | 308.08M |
| 192 | LEGN | Legend Biotech Corporation | 4.06B | -4.03% | 1,930,131 | 1.27B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.93B | 3.09% | 265,977 | 890.79M |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.95% | 1,745,763 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.87B | -2.89% | 1,321,109 | 3.60M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.86B | 0.93% | 786,604 | 234.13M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.84B | -0.73% | 1,251,622 | 117.00M |
| 198 | IOVA | Iovance Biotherapeutics, Inc. | 3.65B | -2.77% | 15,717,213 | 324.97M |
| 199 | OGN | Organon & Co. | 3.61B | - | 4,583,387 | 6.13B |
| 200 | NHC | National HealthCare Corporation | 3.58B | -2.15% | 90,609 | 1.56B |
| 201 | OPCH | Option Care Health, Inc. | 3.55B | -0.13% | 1,679,097 | 5.69B |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.50B | -2.56% | 345,801 | 1.19M |
| 203 | GPCR | Structure Therapeutics Inc. | 3.49B | -0.16% | 822,243 | - |
| 204 | ABCL | AbCellera Biologics Inc. | 3.44B | -6.27% | 6,479,927 | 66.17M |
| 205 | GRAL | GRAIL, Inc. | 3.42B | -3.72% | 380,897 | 165.26M |
| 206 | VCYT | Veracyte, Inc. | 3.33B | -1.99% | 1,156,948 | 561.90M |
| 207 | QURE | uniQure N.V. | 3.29B | -1.88% | 920,824 | 18.67M |
| 208 | TMDX | TransMedics Group, Inc. | 3.25B | -1.23% | 652,802 | 668.47M |
| 209 | WRBY | Warby Parker Inc. | 3.24B | -4.48% | 2,076,667 | 911.61M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -3.66% | 1,154,211 | 7.12M |
| 211 | MBX | MBX Biosciences, Inc. | 3.20B | 0.09% | 530,948 | - |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | 0.15% | 413,947 | 606.33M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.19B | 0.47% | 416,812 | 158.00K |
| 214 | IMNM | Immunome, Inc. | 3.18B | -1.79% | 1,817,476 | 4.02M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -1.20% | 1,128,430 | 463.98M |
| 216 | IRON | Disc Medicine, Inc. | 3.11B | 1.42% | 277,235 | - |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.99B | 4.10% | 5,371,625 | 2.60B |
| 218 | ALMS | Alumis Inc. | 2.98B | -4.72% | 817,366 | 7.40M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.89B | 2.71% | 4,572,738 | 2.93B |
| 220 | SLS | SELLAS Life Sciences Group, Inc. | 2.89B | -7.34% | 8,316,935 | - |
| 221 | ZLAB | Zai Lab Limited | 2.88B | -1.42% | 1,151,324 | 449.61M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.83B | -4.81% | 1,244,097 | 156.04M |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.79B | 2.05% | 3,447,950 | 4.58B |
| 224 | ATAI | AtaiBeckley Inc. | 2.74B | - | 12,304,756 | 4.47M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.73B | -1.68% | 874,202 | 36.77M |
| 226 | VRDN | Viridian Therapeutics, Inc. | 2.72B | -1.11% | 1,131,047 | 71.13M |
| 227 | PRVA | Privia Health Group, Inc. | 2.68B | -0.47% | 876,480 | 2.36B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.67B | 3.24% | 1,438,724 | 3.37B |
| 229 | AXGN | Axogen, Inc. | 2.65B | -2.32% | 704,122 | 251.17M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.62B | -1.61% | 495,460 | 830.44M |
| 231 | RGC | Regencell Bioscience Holdings Limited | 2.62B | -0.19% | 150,105 | - |
| 232 | PHVS | Pharvaris N.V. | 2.62B | 2.87% | 691,816 | - |
| 233 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 0.67% | 1,229,864 | - |
| 234 | PGEN | Precigen, Inc. | 2.57B | -0.42% | 3,347,918 | 85.72M |
| 235 | WGS | GeneDx Holdings Corp. | 2.54B | -2.15% | 504,317 | 454.43M |
| 236 | NEOG | Neogen Corporation | 2.53B | -2.93% | 1,432,914 | 870.40M |
| 237 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | -0.43% | 1,532,989 | 717.00M |
| 238 | NKTR | Nektar Therapeutics | 2.52B | -0.45% | 747,929 | 54.59M |
| 239 | ATRC | AtriCure, Inc. | 2.51B | 0.61% | 438,870 | 569.62M |
| 240 | BHC | Bausch Health Companies Inc. | 2.50B | 3.73% | 2,690,242 | 10.85B |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | 1.36% | 2,010,170 | 940.61M |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 1.38% | 576,003 | 1.10B |
| 243 | CDNA | CareDx, Inc. | 2.46B | -2.28% | 769,370 | 458.09M |
| 244 | VERA | Vera Therapeutics, Inc. | 2.43B | 4.48% | 2,328,411 | - |
| 245 | GRDN | Guardian Pharmacy Services, Inc. | 2.39B | -0.61% | 349,279 | 1.46B |
| 246 | BFLY | Butterfly Network, Inc. | 2.38B | -6.28% | 4,659,231 | 112.14M |
| 247 | NUVB | Nuvation Bio Inc. | 2.37B | -2.45% | 3,012,087 | 169.90M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -2.71% | 2,358,142 | 52.06M |
| 249 | RAPP | Rapport Therapeutics, Inc. | 2.37B | 2.26% | 365,421 | 20.00M |
| 250 | UFPT | UFP Technologies, Inc. | 2.37B | -1.21% | 108,330 | 631.64M |
| 251 | KOD | Kodiak Sciences Inc. | 2.33B | -2.90% | 717,479 | - |
| 252 | GENB | Generate Biomedicines, Inc. | 2.27B | 9.93% | 2,394,652 | 26.48M |
| 253 | ALMR | Alamar Biosciences, Inc. | 2.27B | -4.50% | 302,044 | 100.42M |
| 254 | URGN | UroGen Pharma Ltd. | 2.26B | -1.49% | 849,674 | 188.73M |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 0.92% | 486,051 | 959.90M |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | -1.48% | 587,117 | - |
| 257 | ADUS | Addus HomeCare Corporation | 2.21B | 0.01% | 129,361 | 1.48B |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -0.48% | 686,257 | 311.51M |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.19B | -2.43% | 6,963,852 | 208.78M |
| 260 | MESO | Mesoblast Limited | 2.19B | -2.12% | 177,673 | 65.38M |
| 261 | CLOV | Clover Health Investments, Corp. | 2.18B | -0.96% | 2,759,630 | 2.48B |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.18B | -5.07% | 336,957 | - |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.17B | -0.27% | 2,502,043 | 3.64B |
| 264 | VCEL | Vericel Corporation | 2.17B | -0.89% | 812,268 | 306.30M |
| 265 | XNCR | Xencor, Inc. | 2.16B | 4.30% | 1,049,948 | 104.97M |
| 266 | ESTA | Establishment Labs Holdings Inc. | 2.15B | -0.84% | 243,655 | 245.82M |
| 267 | TRLV | Trulieve Cannabis Corp. | 2.15B | 0.36% | 1,342,664 | 1.14B |
| 268 | KLRA | Kailera Therapeutics, Inc. | 2.14B | -3.67% | 549,359 | - |
| 269 | ADMA | ADMA Biologics, Inc. | 2.14B | -2.95% | 1,962,811 | 512.28M |
| 270 | HCM | HUTCHMED (China) Limited | 2.11B | -3.56% | 56,356 | 549.12M |
| 271 | NEO | NeoGenomics, Inc. | 2.11B | -3.36% | 1,093,873 | 766.30M |
| 272 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.11% | 650,739 | 1.95B |
| 273 | PVLA | Palvella Therapeutics, Inc. | 2.10B | 2.61% | 315,492 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.09B | 0.09% | 475,820 | 27.59M |
| 275 | BHVN | Biohaven Ltd. | 2.07B | -1.23% | 1,308,721 | - |
| 276 | ZBIO | Zenas BioPharma, Inc. | 2.06B | -1.98% | 480,995 | 1.00M |
| 277 | ZYME | Zymeworks Inc. | 2.04B | 0.35% | 822,628 | 37.13M |
| 278 | NBTX | Nanobiotix S.A. | 2.02B | -8.93% | 223,827 | 38.27M |
| 279 | PRGO | Perrigo Company plc | 1.98B | 0.14% | 2,105,013 | 4.14B |
| 280 | CMPS | COMPASS Pathways plc | 1.97B | 6.53% | 2,774,065 | - |
| 281 | PGNY | Progyny, Inc. | 1.95B | -0.78% | 815,345 | 1.31B |
| 282 | NVCR | NovoCure Limited | 1.95B | -1.99% | 1,016,866 | 699.19M |
| 283 | ASTH | Astrana Health, Inc. | 1.95B | -3.15% | 371,359 | 3.84B |
| 284 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -1.36% | 635,627 | 98.34M |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -1.97% | 2,587,509 | 5.49M |
| 286 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.04% | 1,255,422 | - |
| 287 | KARD | Kardigan, Inc. | 1.93B | -1.81% | 279,209 | - |
| 288 | GHRS | GH Research PLC | 1.93B | -0.81% | 162,742 | - |
| 289 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -3.51% | 1,380,832 | 1.97B |
| 290 | SEPN | Septerna, Inc. | 1.89B | 1.30% | 520,417 | 98.88M |
| 291 | IMCR | Immunocore Holdings plc | 1.89B | -0.73% | 371,083 | 430.78M |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.83% | 123,407 | 1.13B |
| 293 | ALVO | Alvotech | 1.87B | 18.51% | 3,173,588 | 494.61M |
| 294 | DMRA | Damora Therapeutics, Inc. | 1.87B | -1.65% | 319,816 | - |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.46% | 326,954 | 481.07M |
| 296 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | 1.51% | 790,344 | 105.60M |
| 297 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -2.32% | 569,875 | 262.43M |
| 298 | PSNL | Personalis, Inc. | 1.82B | -7.18% | 4,792,841 | 69.67M |
| 299 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.24% | 548,520 | 106.69M |
| 300 | SGRY | Surgery Partners, Inc. | 1.81B | -3.93% | 2,148,026 | 3.37B |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.78B | -1.43% | 529,857 | 898.74M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.29% | 101,992 | - |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -2.18% | 3,110,237 | 59.51M |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.41% | 1,443,876 | 252.25M |
| 305 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -7.14% | 15,055,899 | 54.86M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.44% | 1,053,468 | 2.68B |
| 307 | ANAB | AnaptysBio, Inc. | 1.73B | 1.21% | 627,029 | 232.39M |
| 308 | VIR | Vir Biotechnology, Inc. | 1.68B | 1.33% | 1,739,623 | 303.23M |
| 309 | AVLN | Avalyn Pharma Inc. | 1.67B | -1.77% | 158,376 | - |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.64B | 0.58% | 282,274 | 20.00M |
| 311 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 0.46% | 870,742 | 335.41M |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -1.57% | 327,754 | 978.38M |
| 313 | ARDT | Ardent Health, Inc. | 1.59B | 2.37% | 420,267 | 6.41B |
| 314 | OMCL | Omnicell, Inc. | 1.58B | -2.59% | 511,995 | 1.25B |
| 315 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | -0.30% | 167,727 | 95.13M |
| 316 | AGL | agilon health, inc. | 1.57B | -2.89% | 216,018 | 5.92B |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.56B | 0.13% | 559,063 | 1.86B |
| 318 | AAPG | Ascentage Pharma Group International | 1.56B | -1.71% | 6,533 | 94.61M |
| 319 | BCAX | Bicara Therapeutics Inc. | 1.56B | -1.34% | 669,729 | - |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.56B | 0.15% | 235,611 | - |
| 321 | LBRX | LB Pharmaceuticals Inc | 1.56B | 1.24% | 252,629 | - |
| 322 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | 0.39% | 675,209 | - |
| 323 | TNDM | Tandem Diabetes Care, Inc. | 1.55B | -0.45% | 1,064,324 | 1.04B |
| 324 | SLBT | SL Science Holding Limited | 1.55B | 2.26% | 41,833 | 3.27M |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 1.26% | 373,388 | 1.30M |
| 326 | CNMD | CONMED Corporation | 1.54B | 0.82% | 340,034 | 1.37B |
| 327 | INVA | Innoviva, Inc. | 1.52B | -0.19% | 510,221 | 440.00M |
| 328 | ABSI | Absci Corporation | 1.52B | -7.43% | 2,201,291 | 1.56M |
| 329 | INNV | InnovAge Holding Corp. | 1.50B | 0.55% | 195,284 | 949.17M |
| 330 | HROW | Harrow, Inc. | 1.49B | -2.81% | 418,813 | 275.59M |
| 331 | FRNM | Freenome, Inc. | 1.48B | -0.22% | 426,160 | 35.41M |
| 332 | OMDA | Omada Health, Inc. | 1.47B | 0.80% | 942,387 | 309.76M |
| 333 | NVAX | Novavax, Inc. | 1.46B | -0.89% | 5,559,401 | 413.80M |
| 334 | ENOV | Enovis Corporation | 1.45B | -3.26% | 625,289 | 2.30B |
| 335 | AKTS | Aktis Oncology, Inc. | 1.44B | 7.94% | 774,236 | 10.06M |
| 336 | AZTA | Azenta, Inc. | 1.44B | -12.09% | 1,895,680 | 613.81M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.43B | -2.78% | 153,090 | 1.50B |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.43B | -2.53% | 1,716,890 | 815.05M |
| 339 | MGTX | MeiraGTx Holdings plc | 1.42B | 3.42% | 821,211 | 397.50M |
| 340 | ANRO | Alto Neuroscience, Inc. | 1.42B | 5.75% | 867,824 | - |
| 341 | APMD | Apnimed, Inc. | 1.42B | -8.56% | 244,276 | 120.15M |
| 342 | SVRA | Savara Inc. | 1.41B | -0.54% | 1,100,898 | - |
| 343 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 0.65% | 617,258 | - |
| 344 | SDGR | Schrödinger, Inc. | 1.40B | -4.77% | 970,062 | 259.04M |
| 345 | OMER | Omeros Corporation | 1.40B | 0.26% | 1,425,399 | 38.42M |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -5.21% | 1,109,946 | - |
| 347 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.95% | 225,565 | - |
| 348 | LTGO | Latigo Biotherapeutics, Inc. | 1.39B | -1.65% | 234,040 | - |
| 349 | REPL | Replimune Group, Inc. | 1.39B | -0.41% | 2,081,045 | - |
| 350 | PNTG | The Pennant Group, Inc. | 1.36B | 0.03% | 223,129 | 1.10B |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -1.47% | 483,048 | - |
| 352 | JBIO | Jade Biosciences, Inc. | 1.36B | -0.05% | 595,722 | - |
| 353 | VOR | Vor Biopharma Inc. | 1.34B | -2.78% | 499,951 | - |
| 354 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.15% | 384,719 | 3.43B |
| 355 | AORT | Artivion, Inc. | 1.31B | -4.24% | 1,036,003 | 471.47M |
| 356 | MNKD | MannKind Corporation | 1.31B | -1.93% | 2,811,849 | 393.63M |
| 357 | MLTX | MoonLake Immunotherapeutics | 1.31B | -2.47% | 1,137,979 | - |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.30B | -0.30% | 654,653 | 1.65B |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -0.95% | 110,486 | - |
| 360 | NUTX | Nutex Health Inc. | 1.28B | 0.95% | 167,025 | 846.72M |
| 361 | CRON | Cronos Group Inc. | 1.23B | 3.02% | 2,120,559 | 179.09M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -1.98% | 755,579 | 337.34M |
| 363 | CERT | Certara, Inc. | 1.21B | -5.58% | 2,304,596 | 421.75M |
| 364 | ODTX | Odyssey Therapeutics, Inc. | 1.21B | -4.70% | 257,412 | 99.00K |
| 365 | IMTX | Immatics N.V. | 1.19B | -2.69% | 338,049 | 47.65M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -2.56% | 380,165 | - |
| 367 | BVS | Bioventus Inc. | 1.18B | -2.50% | 669,473 | 581.85M |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -3.67% | 1,998,239 | 28.73M |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.17B | -0.29% | 1,120,379 | 785.23M |
| 370 | STAA | STAAR Surgical Company | 1.17B | 0.52% | 562,077 | 339.59M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -1.06% | 171,046 | 804.27M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | -4.59% | 214,074 | 1.04B |
| 373 | JANX | Janux Therapeutics, Inc. | 1.14B | 6.96% | 1,131,625 | 24.00M |
| 374 | SANA | Sana Biotechnology, Inc. | 1.13B | -3.32% | 1,659,729 | - |
| 375 | TDOC | Teladoc Health, Inc. | 1.13B | -2.97% | 3,173,402 | 2.49B |
| 376 | IRMD | IRADIMED CORPORATION | 1.11B | -0.76% | 82,521 | 86.34M |
| 377 | OPK | OPKO Health, Inc. | 1.10B | - | 1,919,349 | 587.90M |
| 378 | KURA | Kura Oncology, Inc. | 1.10B | 4.29% | 2,662,728 | 77.23M |
| 379 | IVA | Inventiva S.A. | 1.09B | 0.43% | 648,488 | 7.94M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.03B | -2.82% | 759,038 | 59.00K |
| 381 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.87% | 1,675,365 | 41.47M |
| 382 | GMRS | GMR Solutions Inc. | 1.03B | -1.78% | 675,393 | 5.88B |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.19% | 18,139,479 | 181.72M |
| 384 | CSTL | Castle Biosciences, Inc. | 1.02B | -2.13% | 356,860 | 357.28M |
| 385 | WVE | Wave Life Sciences, Inc. | 1.01B | -3.21% | 4,553,294 | 65.37M |
| 386 | QDEL | QuidelOrtho Corporation | 993.66M | -1.70% | 1,039,093 | 2.67B |
| 387 | PCRX | Pacira BioSciences, Inc. | 990.97M | 0.77% | 331,107 | 746.16M |
| 388 | CADL | Candel Therapeutics, Inc. | 984.03M | -2.06% | 956,961 | - |
| 389 | SLDB | Solid Biosciences Inc. | 982.18M | -1.51% | 1,114,771 | - |
| 390 | GERN | Geron Corporation | 976.56M | - | 13,099,258 | 204.56M |
| 391 | IMMX | Immix Biopharma, Inc. | 973.65M | -0.37% | 1,419,696 | - |
| 392 | ANNX | Annexon, Inc. | 959.27M | -0.20% | 3,194,931 | - |
| 393 | DSGN | Design Therapeutics, Inc. | 953.12M | 1.60% | 408,409 | - |
| 394 | HELP | Cybin Inc. | 951.24M | 3.42% | 1,862,780 | - |
| 395 | CLYM | Climb Bio, Inc. | 941.95M | -5.09% | 1,177,758 | - |
| 396 | ARDX | Ardelyx, Inc. | 931.96M | -3.86% | 4,762,767 | 450.89M |
| 397 | GLAS | Glass House Brands Inc. | 931.12M | 0.92% | 277,688 | 176.98M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 928.83M | -1.56% | 1,272,811 | 8.22M |
| 399 | CBLL | CeriBell, Inc. | 918.77M | -1.07% | 408,914 | 101.96M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 915.42M | -0.37% | 210,262 | 730.02M |
| 401 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -2.43% | 721,985 | - |
| 402 | ANL | Adlai Nortye Ltd. | 911.87M | 3.36% | 185,760 | 18.06M |
| 403 | FTH | Faeth Therapeutics, Inc. | 896.92M | 8.47% | 448,451 | - |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 890.40M | 0.89% | 758,413 | 808.21M |
| 405 | BBNX | Beta Bionics, Inc. | 887.65M | 3.57% | 864,275 | 119.01M |
| 406 | ATTO | Attovia Therapeutics, Inc. | 887.26M | -0.87% | 80,991 | 1.35M |
| 407 | TBPH | Theravance Biopharma, Inc. | 883.14M | - | 407,232 | 104.31M |
| 408 | SGP | SpyGlass Pharma, Inc. | 878.34M | -0.94% | 70,133 | - |
| 409 | SIBN | SI-BONE, Inc. | 872.62M | -2.45% | 699,824 | 213.60M |
| 410 | INMD | InMode Ltd. | 867.96M | 0.27% | 425,021 | 374.63M |
| 411 | DBVT | DBV Technologies S.A. | 862.94M | -2.82% | 122,736 | 5.04M |
| 412 | AVR | Anteris Technologies Global Corp. | 857.63M | -2.00% | 802,500 | 2.24M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 850.21M | -2.78% | 1,474,707 | 92.01M |
| 414 | RIGL | Rigel Pharmaceuticals, Inc. | 842.65M | -1.70% | 416,630 | 276.79M |
| 415 | HSTM | HealthStream, Inc. | 841.53M | -0.31% | 200,013 | 321.12M |
| 416 | PHAR | Pharming Group N.V. | 839.49M | -3.29% | 23,168 | 366.48M |
| 417 | AURA | Aura Biosciences, Inc. | 819.27M | 1.28% | 843,809 | - |
| 418 | ACHV | Achieve Life Sciences, Inc. | 817.05M | -0.63% | 920,287 | - |
| 419 | OCS | Oculis Holding AG | 813.63M | 0.73% | 150,346 | 1.45M |
| 420 | OBX | Obsidian Therapeutics, Inc. | 810.20M | -6.03% | 133,093 | - |
| 421 | AHG | Akso Health Group | 807.91M | 1.44% | 3,721 | 13.83M |
| 422 | SLN | Silence Therapeutics plc | 796.57M | -0.30% | 721,979 | 615.00K |
| 423 | NGNE | Neurogene Inc. | 793.25M | 2.61% | 439,094 | 925.00K |
| 424 | STTK | Shattuck Labs, Inc. | 792.87M | 4.91% | 2,054,932 | 1.00M |
| 425 | VREX | Varex Imaging Corporation | 780.58M | 0.05% | 635,135 | 865.00M |
| 426 | NVCT | Nuvectis Pharma, Inc. | 777.72M | 1.32% | 231,127 | - |
| 427 | DRUG | Bright Minds Biosciences Inc. | 774.85M | -0.51% | 107,834 | - |
| 428 | AHCO | AdaptHealth Corp. | 751.09M | - | 1,743,073 | 3.36B |
| 429 | MNPR | Monopar Therapeutics Inc. | 747.47M | 3.38% | 239,170 | - |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 732.79M | 0.66% | 338,518 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 726.33M | -1.05% | 131,534 | 11.88M |
| 432 | PHR | Phreesia, Inc. | 722.58M | -3.55% | 626,480 | 495.59M |
| 433 | SOPH | SOPHiA GENETICS SA | 719.33M | -2.31% | 655,538 | 86.17M |
| 434 | ASMB | Assembly Biosciences, Inc. | 718.32M | 2.62% | 383,866 | 74.85M |
| 435 | CTMX | CytomX Therapeutics, Inc. | 716.89M | 0.30% | 3,191,673 | 18.30M |
| 436 | TECX | Tectonic Therapeutic, Inc. | 712.97M | -3.08% | 222,279 | - |
| 437 | SCTX | Scribe Therapeutics Inc. | 702.70M | 9.14% | 543,973 | 36.28M |
| 438 | SSII | SS Innovations International, Inc. | 701.35M | -2.37% | 49,818 | 52.40M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 701.35M | -2.87% | 4,336,740 | 4.64M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -1.85% | 784,381 | 136.07M |
| 441 | PHAT | Phathom Pharmaceuticals, Inc. | 687.86M | -2.37% | 992,684 | 239.66M |
| 442 | OABI | OmniAb, Inc. | 684.79M | 8.78% | 1,937,827 | 38.46M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 682.86M | -6.80% | 53,275 | 109.82M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 682.44M | -3.73% | 1,380,961 | 389.32M |
| 445 | EVO | Evotec SE | 680.72M | -2.07% | 22,638 | 819.47M |
| 446 | PRLD | Prelude Therapeutics Incorporated | 666.38M | -2.41% | 515,609 | 22.42M |
| 447 | KIDS | OrthoPediatrics Corp. | 654.57M | -2.26% | 154,212 | 252.72M |
| 448 | ANGO | AngioDynamics, Inc. | 651.81M | 0.13% | 179,113 | 320.17M |
| 449 | CRMD | CorMedix Inc. | 645.38M | 0.98% | 1,012,097 | 462.25M |
| 450 | TLRY | Tilray Brands, Inc. | 640.10M | -2.48% | 2,968,726 | 915.45M |
| 451 | VALN | Valneva SE | 635.77M | -3.16% | 21,945 | 163.30M |
| 452 | SGMT | Sagimet Biosciences Inc. | 634.64M | -0.39% | 1,242,172 | - |
| 453 | AGMB | AgomAb Therapeutics NV | 631.36M | -3.25% | 31,651 | - |
| 454 | CTNM | Contineum Therapeutics, Inc. | 625.64M | -3.26% | 261,078 | - |
| 455 | STLN | Starling Oncology, Inc. | 624.75M | -5.18% | 1,228,771 | 587.24M |
| 456 | AUTL | Autolus Therapeutics plc | 622.82M | -2.90% | 1,222,452 | 117.39M |
| 457 | MDXG | MiMedx Group, Inc. | 622.40M | -1.39% | 846,655 | 355.17M |
| 458 | VSTM | Verastem, Inc. | 621.27M | -0.44% | 1,166,440 | 87.53M |
| 459 | CTEV | Claritev Corporation | 619.94M | -1.85% | 76,189 | 994.67M |
| 460 | ARVN | Arvinas, Inc. | 610.71M | -0.27% | 500,357 | 316.70M |
| 461 | ALT | Altimmune, Inc. | 604.95M | - | 2,714,551 | 31.00K |
| 462 | EIKN | Eikon Therapeutics, Inc. | 604.48M | -2.02% | 398,267 | - |
| 463 | ZURA | Zura Bio Limited | 603.72M | 7.69% | 8,076,615 | - |
| 464 | AQST | Aquestive Therapeutics, Inc. | 602.46M | 3.00% | 2,493,452 | 54.09M |
| 465 | ENTX | Entera Bio Ltd. | 592.15M | 5.88% | 257,945 | 42.00K |
| 466 | WEAV | Weave Communications, Inc. | 583.19M | - | 2,998,441 | 257.79M |
| 467 | DCTH | Delcath Systems, Inc. | 581.20M | -2.28% | 417,035 | 95.42M |
| 468 | EOLS | Evolus, Inc. | 579.92M | 4.65% | 1,320,147 | 316.49M |
| 469 | PRME | Prime Medicine, Inc. | 578.19M | -4.13% | 2,266,016 | 4.07M |
| 470 | CTKB | Cytek Biosciences, Inc. | 577.13M | -7.69% | 943,482 | 206.71M |
| 471 | BWAY | BrainsWay Ltd. | 572.43M | -3.73% | 97,711 | 60.70M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 563.21M | 5.40% | 306,971 | 251.00K |
| 473 | OVID | Ovid Therapeutics Inc. | 550.74M | 0.71% | 1,229,613 | 1.58M |
| 474 | CERS | Cerus Corporation | 542.10M | -4.27% | 1,623,332 | 221.55M |
| 475 | FLGT | Fulgent Genetics, Inc. | 535.17M | -2.26% | 259,914 | 323.93M |
| 476 | EVH | Evolent Health, Inc. | 533.64M | -0.42% | 1,735,939 | 2.10B |
| 477 | SPRY | ARS Pharmaceuticals, Inc. | 532.04M | -2.82% | 1,935,965 | 116.93M |
| 478 | RGNX | REGENXBIO Inc. | 531.74M | -24.86% | 5,441,073 | 174.48M |
| 479 | TCMD | Tactile Systems Technology, Inc. | 529.16M | -1.93% | 263,908 | 350.31M |
| 480 | SRTA | Strata Critical Medical, Inc. | 528.15M | -4.33% | 887,427 | 255.98M |
| 481 | MPLT | MapLight Therapeutics, Inc. | 526.85M | 1.34% | 563,147 | - |
| 482 | CABA | Cabaletta Bio, Inc. | 525.59M | -0.96% | 3,107,001 | - |
| 483 | RZLT | Rezolute, Inc. | 523.38M | -1.57% | 1,297,270 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 509.59M | -2.14% | 565,129 | - |
| 485 | CCCC | C4 Therapeutics, Inc. | 504.40M | 2.50% | 1,751,975 | 35.04M |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | EVMN | Evommune, Inc. | 496.11M | -2.50% | 228,578 | 10.00M |
| 488 | SENS | Senseonics Holdings, Inc. | 495.96M | -3.40% | 855,449 | 48.55M |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 491.22M | -2.14% | 155,960 | - |
| 490 | KMDA | Kamada Ltd. | 490.54M | 2.31% | 198,828 | 191.85M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 488.55M | -1.08% | 935,746 | - |
| 492 | QTTB | Q32 Bio Inc. | 487.03M | 2.44% | 690,838 | 53.74M |
| 493 | PROK | ProKidney Corp. | 486.74M | - | 980,539 | 818.00K |
| 494 | NRC | NRC Health | 484.86M | -1.22% | 72,704 | 140.00M |
| 495 | PRTA | Prothena Corporation plc | 482.05M | -0.63% | 248,117 | 54.53M |
| 496 | NPCE | NeuroPace, Inc. | 480.20M | -0.29% | 117,659 | 106.99M |
| 497 | PBYI | Puma Biotechnology, Inc. | 470.78M | -1.30% | 266,136 | 231.24M |
| 498 | CLPT | ClearPoint Neuro, Inc. | 462.75M | -1.43% | 421,959 | 42.28M |
| 499 | SI | Shoulder Innovations, Inc. | 462.60M | 0.73% | 75,050 | 60.06M |
| 500 | SGHT | Sight Sciences, Inc. | 461.64M | 1.45% | 169,627 | 83.38M |